NSPR Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.8M
-47.9%
3.4M
+7.9%
3.1M
+24.8%
2.5M
+41.9%
1.8M
Cost of Revenue
2.5M
-6.1%
2.7M
+37.7%
2.0M
+18.7%
1.7M
+13.2%
1.5M
Gross Profit
-774000
-212.7%
687.0K
-41.8%
1.2M
+36.6%
864.0K
+176.0%
313.0K
Operating Expenses
13.7M
-6.8%
14.7M
+10.6%
13.3M
-4.7%
13.9M
+4.4%
13.3M
R&D
4.3M
-9.8%
4.8M
+37.1%
3.5M
-4.4%
3.6M
-5.2%
3.8M
SG&A
9.4M
-5.3%
9.9M
+1.2%
9.8M
-4.8%
10.3M
+8.2%
9.5M
Operating Income
-14445000
-3.3%
-13978000
-15.7%
-12084000
+7.4%
-13051000
-0.2%
-13019000
EBITDA
-14287000
-3.3%
-13829000
-15.8%
-11941000
+7.6%
-12923000
-0.1%
-12912000
Net Income
-14324000
-4.6%
-13689000
-16.4%
-11761000
+7.5%
-12708000
+3.4%
-13151000
EPS (Basic)
$-0.17
-6.3%
$-0.16
-14.3%
$-0.14
+17.6%
$-0.17
+34.6%
$-0.26
EPS (Diluted)
$-0.17
-6.3%
$-0.16
-14.3%
$-0.14
+17.6%
$-0.17
+34.6%
$-0.26
Shares (Diluted)
84.7M
+1.0%
83.8M
+1.2%
82.8M
+12.8%
73.5M
+44.0%
51.0M
InspireMD (NSPR) โ€” Financials